New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis

Université Lille Nord de France, ICPAL, EA 4481, IFR114, 3 rue du Professeur Laguesse, BP-83, F-59006 Lille, France.
Bioorganic & medicinal chemistry (Impact Factor: 2.79). 06/2011; 19(12):3777-86. DOI: 10.1016/j.bmc.2011.04.057
Source: PubMed


Growing evidence suggests a role for the endocannabinoid (EC) system, in intestinal inflammation and compounds inhibiting anandamide degradation offer a promising therapeutic option for the treatment of inflammatory bowel diseases. In this paper, we report the first series of carboxamides derivatives possessing FAAH inhibitory activities. Among them, compound 39 displayed significant inhibitory FAAH activity (IC(50) = 0.088 mu M) and reduced colitis induced by intrarectal administration of TNBS.

Download full-text


Available from: Madjid Djouina, Aug 05, 2014
34 Reads
  • Source
    • "This is seen in the conclusions to many studies incorporating such models, or indeed articles reviewing the use of these models, which tend to finish with statements referring to future, rather than current, therapeutic advances. Some examples of such conclusions are as follows (note that italics are not in the original references): " ...promising target for the Inflammatory Bowel Diseases (IBD) treatment " (Andrzejak et al., 2011); " substantial investment from the pharmaceutical industry should deliver novel therapies arising from gene discovery to the clinic within the next 5 years " (Lees et al., 2011); " ...recently established genetically engineered mouse models lacking IBD susceptibility gene should be promising tools to develop novel therapeutic measures for IBD " (Mizoguchi and Mizoguchi, 2010). This is not to detract from some excellent research in the field, and the recently established genetically engineered mouse models lacking IBD susceptibility genes should indeed prove to be promising tools to develop novel therapies. "
    Ulcerative Colitis - Treatments, Special Populations and the Future, 11/2011; , ISBN: 978-953-307-739-0
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The asymmetric unit of the title compound, C(12)H(12)N(2)O(3), contains two mol-ecules in which the benzene and isoxazole rings are almost coplanar, the dihedral angles between their mean planes being 1.76 (9) and 5.85 (8)°. The two mol-ecules inter-act with each other via N-H⋯N and N-H⋯O hydrogen bonds, which link the mol-ecules into layers parallel to the ac plane. The layers stack in a parallel mode with an inter-layer distance of 3.36 (7) Å.
    Acta Crystallographica Section E Structure Reports Online 04/2012; 68(Pt 4):o1111. DOI:10.1107/S1600536812010653 · 0.35 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Crohn's disease and ulcerative colitis are two major forms of inflammatory bowel diseases (IBD), which are chronic inflammatory disorders of the gastrointestinal tract. These pathologies are currently under investigation to both unravel their etiology and find novel treatments. Anandamide and 2-arachidonoylglycerol are endogenous bioactive lipids that bind to and activate the cannabinoid receptors, and together with the enzymes responsible for their biosynthesis and degradation [fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL)] constitute the endocannabinoid system (ECS). The ECS is implicated in gut homeostasis, modulating gastrointestinal motility, visceral sensation, and inflammation, as well as being recently implicated in IBD pathogenesis. Numerous subsequent studies investigating the effects of cannabinoid agonists and endocannabinoid degradation inhibitors in rodent models of IBD have identified a potential therapeutic role for the ECS.
    Trends in Molecular Medicine 08/2012; 18(10):615-25. DOI:10.1016/j.molmed.2012.07.009 · 9.45 Impact Factor
Show more